A clinical trial looking at the combination of a personalized mRNA cancer vaccine from Moderna and Merck's immunotherapy drug Keytruda reportedly showed that this treatment can work to help prevent a recurrence of skin cancer.
| | | | Skin Cancer: Vaccine May Help Prevent it From Returning | A clinical trial looking at the combination of a personalized mRNA cancer vaccine from Moderna and Merck's immunotherapy drug Keytruda reportedly showed that this treatment can work to help prevent a recurrence of skin cancer. | | | | | | | | | | | |
No comments:
Post a Comment